AnalyzeDirect Pavese N, Rivero-Bosch M, Lewis SJ, Whone AL, Brooks DJ. Progression of monoaminergic dysfunction in Parkinson’s disease: a longitudinal 18F-dopa PET study. Neuroimage. June 2011;56(3):1463-1468.
Publication Date
June 2011
How Analyze was Used
“The standard object map was applied to the spatially normalised K i maps and the values for specific 18F-dopa uptake in individual regions were extracted using ANALYZE 8.1 software.”
Keywords
Amino Acid Transport Systems, Neutral/metabolism
Antiparkinson Agents/therapeutic use
Biogenic Monoamines/physiology
Decarboxylation
Dihydroxyphenylalanine/analogs & derivatives/diagnostic use
Dopamine/metabolism/physiology
Female
Follow-Up Studies
Humans
Image Processing, Computer-Assisted
Levodopa/therapeutic use
Longitudinal Studies
Male
Middle Aged
Norepinephrine/metabolism/physiology
Parkinson Disease/physiopathology/radionuclide imaging
Positron-Emission Tomography (PET)
Radiopharmaceuticals/diagnostic use
Serotonin/metabolism/physiology
Author Affiliation(s)
Centre for Neuroscience, Department of Medicine, Imperial College London, London, UK.
ID# 782
Tags: Antiparkinson Agents/therapeutic use, Biogenic Monoamines/physiology, Computer-Assisted Image Processing, Decarboxylation, Dihydroxyphenylalanine/analogs & derivatives/diagnostic use, Dopamine/metabolism/physiology, Female, Follow-Up Studies, Humans, Levodopa/therapeutic use, Longitudinal Studies, Male, Middle Aged, Neutral Amino Acid Transport Systems/metabolism, Norepinephrine/metabolism/physiology, Parkinson Disease/physiopathology/radionuclide imaging, Positron Emission Tomography (PET), Radiopharmaceuticals/diagnostic use, Serotonin/metabolism/physiology